{
  "ticker": "BXN",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959779",
  "id": "02959779",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250618",
  "time": "1808",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250618/pdf/06kw9ngr6748vq.pdf",
  "summary": "- **Webinar rescheduled** to 19 June 2025 (5:00 PM AEST) due to technical issues.  \n- **Key discussion topics**: FY2025 revenue guidance, Australia/UK/EU market updates, MDMA developments.  \n- **FY2026 outlook**: Expected growth from expansion in Australia, UK, Germany, and EU; guidance to be provided in August 2025.  \n\n*No material trading or capital markets impacts identified.*",
  "usage": {
    "prompt_tokens": 1265,
    "completion_tokens": 96,
    "total_tokens": 1361,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-18T08:33:49.248091"
}